Obstetrics & Gynecology · Elkhorn, NE
NPI
1588860894
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
717 N 190th Plz, Ste. 1100
Elkhorn, NE, 68022
Phone (402) 815-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,586
95 services
Medicare patients, 2024
35
Average age 69
Drug cost, 2024
$6,369
33 prescriptions
Company payments, 2025
$251
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan L Prickett was code 77063 (mammography), 22 times for 22 patients. In total Megan L Prickett billed 95 services in 25 codes, and Medicare paid $4,586.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77063 Mammography | Office | 22 | 22 | $21.52 | $474 |
| 77067 Mammography | Office | 22 | 22 | $82.60 | $1,817 |
By year: 2022 $3,795 for 82 services; 2023 $4,186 for 93 services; 2024 $4,586 for 95 services.
Medicare prescription drug claims, 2024
In 2024, the drug Megan L Prickett prescribed most often to Medicare patients was Lo Loestrin Fe (Norethindrone-E.Estradiol-Iron), with 13 prescriptions and refills. In total Megan L Prickett wrote 33 Medicare prescriptions that cost $6,369.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lo Loestrin Fe Norethindrone-E.Estradiol-Iron | 13 | 13 | Under 11 | $2,495 |
Brand drugs: 17 claims; generic drugs: 16 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan L Prickett $251 ($251 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $135.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.